Compare ACHV & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACHV | FNWD |
|---|---|---|
| Founded | N/A | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.0M | 140.6M |
| IPO Year | 2018 | 1996 |
| Metric | ACHV | FNWD |
|---|---|---|
| Price | $4.98 | $33.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $14.67 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 1.5M | 6.9K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.52 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.40 |
| Revenue Next Year | N/A | $5.44 |
| P/E Ratio | ★ N/A | $65.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.00 | $26.46 |
| 52 Week High | $6.16 | $39.99 |
| Indicator | ACHV | FNWD |
|---|---|---|
| Relative Strength Index (RSI) | 43.99 | 59.59 |
| Support Level | $4.09 | $31.24 |
| Resistance Level | $4.98 | $35.27 |
| Average True Range (ATR) | 0.42 | 1.11 |
| MACD | -0.05 | 0.16 |
| Stochastic Oscillator | 8.59 | 70.21 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.